Strategic Phased Launch of Tirzepatide for Obes...

By João L. Carapinha

October 8, 2024

The phased launch of tirzepatide obesity treatment, is a significant development in combating obesity. The obesity injection, also known as Mounjaro or Zepbound, is developed by Eli Lilly and aims to provide a new treatment option for those strugg...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.